Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2003

View Archived Issues

BILS-45-BS demonstrates significant efficacy against aciclovir-resistant HSV-1

Comorbid disorders reported to reduce the response to paroxetine in OCD

Intravesical rhIL-12 in recurrent STCC of the bladder

Beneficial effects described for thymosin beta4 in septic shock

CB-300638, a thmidylate synthase inhibitor with potential as an antitumor agent

FDA approval for Crestor

Tumor necrosis therapy receives marketing approval for lung cancer in China

Phase IIIb results support use of diquafosol in dry eye

AlphaCor introduction for cornea transplant patients who reject human tissue

DakoCytomation acquires rights to H. pylori detection test

Predix and Physiome Sciences merge

BMS files IND for p38 kinase inhibitor for rheumatoid arthritis

ICN expands Kinerase license with Senetek

Q2 developments at Xoma

Angiotech: Q3 progress

NPS offers late-stage development progress report

Encysive reports on recent events

Guilford patent covers new PARP inhibitors and their use

Scientists at Sumitomo identify novel PPARdelta agonists

Takeda develops new fusion inhibitors for AIDS therapy

New hair growth-promoting agents prepared and tested at Kao

Japanese team presents new compounds with proapoptotic and cell adhesion-inhibitory activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...